BackRigel Pharmaceuticals Overview

Rigel Pharmaceuticals Total Liabilities

Rigel Pharmaceuticals's total liabilities is $95M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$95.42M
↓ 23.55% YoYΔ $-29.39M vs prior year quarter

Peer trimmed avg / median

Loading

Rigel Pharmaceuticals Total Liabilities History

Loading

Rigel Pharmaceuticals vs. peers: Total Liabilities Comparison

Loading

Rigel Pharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Rigel Pharmaceuticals (RIGL) FAQ

As of the most recent data (June 2026), RIGL shows a total liabilities of $95M. That compares with $120M in the prior-year period — down 23.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RIGL's total liabilities is now $95M (was $120M) — a 23.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rigel Pharmaceuticals is outperforming or lagging.

Tracking RIGL's total liabilities over time shows whether Rigel Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $95M That compares with $120M in the prior-year period — down 23.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Rigel Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $95M) with ownership activity and broader fundamentals.

Rigel Pharmaceuticals's total liabilities is $95M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.